The DOI matches its Crossref record.
Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization
Abstract
BACKGROUND: In response to rising prescription drug costs, plan sponsors are increasingly implementing three-tiered pharmacy benefits. OBJECTIVE: This study examined the effect of a three-tiered pharmacy benefit on pharmaceutical utilization and expenditures, medication continuation, and use of other medical resources in a population of continuously eligible, commercially insured enrollees of a preferred provider organization (PPO). RESEARCH DESIGN: A quasi-experimental prepost with comparison group design was used. The pre- and postperiods were each 12 months long. SUBJECTS: The intervention group included enrollees whose employer moved from the PPO's two-tier benefit to a three-tier benefit (n = 6881). The comparison group included enrollees whose employer remained under the PPO's two-tier benefit (n = 13,279). MEASURES: Key dependent variables included total prescription claims and costs, net costs (total minus copay), medication continuation, office visits, and inpatient and emergency room use. RESULTS: Relative to the comparison group, the intervention group experienced lower prescription utilization and expenditures and reduced net costs. Medication continuation rates were lower at 6 and 11 months in one of four chronic therapy classes examined; however, discontinuation could not be clearly linked to tier-three medication use. No significant differences in physician office visits, inpatient, or emergency room use rates were found. CONCLUSIONS: Three-tier prescription copays can control drug costs without evidence of change in use of other medical resources in the year following implementation. Future research should examine a variety of three-tier designs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Goldman, D. P., Joyce, G. F., & Zheng, Y. (2007) · JAMA · doi:10.1001/jama.298.1.61 · Cited by 874
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Goldman, D. P. (2004) · JAMA · doi:10.1001/jama.291.19.2344 · Cited by 530
Shrank, W. H., Hoang, T., Ettner, S. L., Glassman, P. A., Nair, K., DeLapp, D., Dirstine, J., Avorn, J., & Asch, S. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.332 · Cited by 343
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.
Luiza, V. L., Chaves, L. A., Silva, R. M., Emmerick, I. C. M., Chaves, G. C., Fonseca de Araújo, S. C., Moraes, E. L., & Oxman, A. D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007017.pub2 · Cited by 102
Happe, L. E., Clark, D., Holliday, E., & Young, T. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.7.677 · Cited by 69
Metadata
- Authors
- Motheral, B., & Fairman, K. A.
- Venue
- Medical Care
- Published
- 2001-12
- Volume
- 39
- Issue
- 12
- Pages
- 1293-1304
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2314140878
- Cited by
- 161
- References
- 0
- FWCI
- 29.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization. https://app.cochat.ai/papers/10.1097/00005650-200112000-00005
- The paper
- Motheral, B., & Fairman, K. A. (2001). Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization. Medical Care. https://doi.org/10.1097/00005650-200112000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.